Skip to main content

Showing results for Cancer

IU School of Medicine researchers discover small molecule degrader as potential anticancer drug

Researchers in the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine have discovered a novel anti-cancer drug, using a unique approach that has allowed them to target previously undruggable cancerous proteins. 

IU School of Medicine  |  Oct 19, 2021

IU Simon Comprehensive Cancer Center names its first associate director of diversity, equity and inclusion

The Indiana University Melvin and Bren Simon Comprehensive Cancer Center has named Antwione Haywood, PhD, its associate director of diversity, equity and inclusion (DEI). Haywood is the first person to hold the chief diversity officer position at the cancer center. 

IU School of Medicine  |  Oct 18, 2021

Cancer center researchers part of a collaborative $12.4 million SPORE grant from National Cancer Institute

Two Indiana University Melvin and Bren Simon Comprehensive Cancer Center researchers are now part of a prestigious Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute.

IU School of Medicine  |  Sep 28, 2021

Brown Center for Immunotherapy names Huda Salman, MD, PhD as inaugural executive director

Indiana University School of Medicine has named its first executive director of the Brown Center for Immunotherapy. Huda Salman, MD, PhD will become the center’s new leader, effective November 1.

Christina Griffiths  |  Sep 15, 2021

IU cancer researcher unlocks new approach for possible pancreatic cancer treatment

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified how restoring a missing molecule in pancreatic fibrosis could help deliver treatments to cancer cells.

IU School of Medicine  |  Aug 31, 2021

IU cancer researcher receives $2.5 million grant to develop lung cancer treatment

INDIANAPOLIS—A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.5 million grant from the National Cancer Institute to develop a novel therapy to treat lung cancer.

Christina Griffiths  |  Aug 30, 2021

IU School of Medicine research team discovers drug target, pathway for treating muscle and fat wasting in pancreatic cancer patients

A team of all Indiana University School of Medicine researchers have discovered a novel drug target to treat involuntary muscle and fat wasting, known as cachexia, in people with pancreatic cancer.

IU School of Medicine  |  Jun 29, 2021

IU School of Medicine researchers develop computer program to predict whether patients could be at high risk for Alzheimer’s and cancer

A group of researchers from Indiana University School of Medicine and Indiana University Bloomington have developed a program called Multi-Omics Graph cOnvolutional NETworks (MOGONET) that integrates omics data – such as DNA, RNA and proteins – to help researchers get a comprehensive understanding of human diseases. MOGONET can identify potential biomarkers for Alzheimer’s disease and cancers from the various omics data to predict which individuals may be at higher risk. 

IU School of Medicine  |  Jun 23, 2021

Cancer center joins call for urgent action to get cancer-preventing HPV vaccination back on track

Indiana University Melvin and Bren Simon Comprehensive Cancer Center has joined National Cancer Institute (NCI)-designated cancer centers and other organizations in a joint statement urging the nation’s health care systems, physicians, parents and children, and young adults to get the human papillomavirus (HPV) vaccination back on track.

IU School of Medicine  |  May 25, 2021

Cancer researchers study cognitive dysfunction after chemotherapy

Cancer researchers at Indiana University and the University of Pittsburgh received a five-year, $3 million grant from the National Cancer Institute (NCI) to study cognitive dysfunction after chemotherapy. 

IU School of Medicine  |  May 04, 2021